Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/30/2025

Rate of Transfusion of PRBC in CKD

Transfusion Protocol Specifics

  • The American College of Physicians recommends ordering precisely 1 unit of PRBCs at a time rather than ordering multiple units simultaneously, and to perform a clinical reassessment before deciding whether to order an additional unit 1
  • Each 300 mL unit of PRBCs typically raises hemoglobin by 1 g/dL or hematocrit by 3% in normal-sized adults without ongoing blood loss 1
  • No mandatory waiting period exists between units for stable patients—the decision to transfuse additional units should be based on clinical reassessment, not arbitrary time intervals 1

When to Transfuse in CKD

  • The Kidney International guidelines suggest avoiding red cell transfusions when possible to minimize general risks related to their use, and that transfusion is rarely indicated when the hemoglobin level is greater than 10 g/dL 2
  • The National Comprehensive Cancer Network recommends that the benefits of red cell transfusions may outweigh the risks in CKD patients when ESA therapy is ineffective or when the risks of ESA therapy may outweigh its benefits 2
  • For CKD patients on dialysis receiving ESA therapy, the target hemoglobin range is generally between 11.0-12.0 g/dL, and hemoglobin levels above 13.0 g/dL should be avoided due to increased risk of life-threatening cardiovascular events 4

Critical Risks Specific to CKD Patients

  • In cancer patients, including some CKD patients, PRBC transfusion carries increased risks of venous thromboembolism, arterial thromboembolism, and mortality 1
  • The Kidney International guidelines recommend avoiding red cell transfusions when possible in patients eligible for organ transplantation to minimize the risk of allosensitization 2

Common Pitfalls to Avoid

  • The Kidney International guidelines suggest not assuming transfusion corrects underlying iron deficiency, and to obtain pre-transfusion iron indices and provide supplemental iron therapy if needed in the 90 days following transfusion 1
  • The Kidney International guidelines recommend avoiding routine volume reduction of PRBCs, as 15-55% of platelets are lost during additional centrifugation steps 1
  • The Kidney International guidelines suggest not transfusing based solely on a hemoglobin number without considering the clinical context, symptoms, and whether alternative therapies are appropriate 2

Alternative Management Before Transfusion

  • The Praxis Medical Insights guidelines recommend ensuring adequate iron stores are maintained with TSAT ≥20% and serum ferritin ≥100 ng/mL to support erythropoiesis, and to preferentially use intravenous iron in hemodialysis patients 4
  • The Praxis Medical Insights guidelines suggest monitoring iron status by measuring TSAT and serum ferritin at least every 3 months 4

REFERENCES

1

Transfusion of Packed Red Blood Cells [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Management of Autoimmune Hemolytic Anemia in Patients with Chronic Kidney Disease on Dialysis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025